Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.

Nichol KL.

Vaccine. 2011 Oct 6;29(43):7554-8. doi: 10.1016/j.vaccine.2011.08.015. Review.

PMID:
21820477
2.

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ.

Pharmacoeconomics. 1999;16 Suppl 1:33-40. Review.

PMID:
10623374
3.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT.

Drugs. 2002;62(7):1013-24. Review.

PMID:
11985488
4.

[Pharmaco-economics of anti-influenza vaccinations].

Jahnz-Rózyk K.

Pol Merkur Lekarski. 2003 Jun;14(84):679-81. Review. Polish.

PMID:
14524303
5.

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Newall AT, Kelly H, Harsley S, Scuffham PA.

Pharmacoeconomics. 2009;27(6):439-50. doi: 10.2165/00019053-200927060-00001. Review.

PMID:
19640008
6.

[An economic evaluation of strategy for expanding influenza vaccination in Japan].

Hara Y.

Nihon Rinsho. 2003 Nov;61(11):2013-8. Review. Japanese.

PMID:
14619447
7.

Economic evaluations of childhood influenza vaccination: a critical review.

Newall AT, Jit M, Beutels P.

Pharmacoeconomics. 2012 Aug 1;30(8):647-60. doi: 10.2165/11599130-000000000-00000. Review.

PMID:
22788257
8.

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.

9.

Medical economics in the field of influenza--past, present and future.

Szucs TD.

Virus Res. 2004 Jul;103(1-2):25-30. Review.

PMID:
15163484
10.

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.

PMID:
16277546
11.

Economic value of influenza vaccination.

de Waure C, Veneziano MA, Cadeddu C, Capizzi S, Specchia ML, Capri S, Ricciardi W.

Hum Vaccin Immunother. 2012 Jan;8(1):119-29. doi: 10.4161/hv.8.1.18420. Review.

PMID:
22251999
12.

Influenza cost and cost-effectiveness studies globally--a review.

Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA.

Vaccine. 2013 Nov 4;31(46):5339-48. doi: 10.1016/j.vaccine.2013.09.013. Review.

PMID:
24055351
13.

Are we ready for universal influenza vaccination in paediatrics?

Principi N, Esposito S.

Lancet Infect Dis. 2004 Feb;4(2):75-83. Review.

PMID:
14871631
14.

Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.

Myers ER, Misurski DA, Swamy GK.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S128-40. doi: 10.1016/j.ajog.2011.04.009. Review.

PMID:
21640230
15.

Evaluating the impact of influenza vaccination. A North American perspective.

Fedson DS.

Pharmacoeconomics. 1996;9 Suppl 3:54-61. Review.

PMID:
10160488
16.

[Flu vaccine in children: state of the art].

Vega-Briceño LE, Abarca V K, Sánchez D I.

Rev Chilena Infectol. 2006 Jun;23(2):164-9. Review. Spanish. Erratum in: Rev Chilena Infectol. 2006 Sep;23(3):276.

17.

Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.

Poland GA, Rottinghaus ST, Jacobson RM.

Vaccine. 2001 Mar 21;19(17-19):2216-20. Review.

PMID:
11257336
18.

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Jit M, Newall AT, Beutels P.

Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Review.

19.

[Influenza vaccination of children as a general factor in prevention of influenza epidemics].

Gendon IuZ.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):78-85. Review. Russian.

PMID:
17886380
20.

Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC.

Drugs Aging. 2000 Sep;17(3):217-27. Review.

PMID:
11043820

Supplemental Content

Support Center